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Summary: Results obtained with the in vitro Wilson- Wiseman method ((1954), J. Physiol. 123,116-125) and
with an in vivo perfusion model are compared. The in vitro method suffers from insufficient oxygenation. Five
plasma membrane enzymes, five cytosol and two lysosomal enzymes were estimated. The medium consisted
of Ringer solution without and with 10 mmol/1 taurocholate. The greatest difference between both models is
shown by the lysosomal enzymes, which are amply released in vitro but not in vivo. The in vitro to in vivo
ratios of the release rates of cytosol enzymes vary from about 10 to less than one, suggesting deterioration by
lysosomal cathepsins in certain cases. The removal of plasma membrane enzymes, particularly those that are
characterized by superficial localization, is inhibited by hypoxia. This implies that the normal release of these
enzymes, at least in part, is energy-dependent.
Freisetzung von Enzymen aus der Jejunumschleimhaut der Ratte bei Inkubation in vitro
Zusammenfassung: Es werden Ergebnisse verglichen, die mit der in vitro Wilson- Wiseman-Meihode ((1954),
J. Physiol. 723, 116—125) und mit einem in vivo-Perfusionsmodell erhalten wurden. Die in vitro-Methode
leidet unter ungenügender Oxygenierung. 5 Plasmamembran-', 5 Cytosol- und 2 lysosomale Enzyme wurden
bestimmt. Das Medium bestand aus Ringer-Lösung ohne und mit 10 mmol/1 Taurocholat. Den größten Un-
terschied zwischen beiden Modellen zeigen die lysosomalen Enzyme, die in vitro, nicht aber in vivo reichlich
freigesetzt werden. Das Verhältnis der Freisetzüngsraten von Cytosolenzymen in vitro und in vivo schwankt
von etwa 10 bis weniger als 1. In gewissen Fällen scheint ein Abbau durch lysosomale Kathepsine eine Rolle
zu spielen. Die Ablösung von Plasmamembranenzymen, besonders der oberflächlich lokalisierten, ist bei
Hypoxie gehemmt. Demnach wäre die normale Freisetzung dieser Enzyme wenigstens teilweise energieab-
hängig.
Introduction
In a previoüs paper (1) the release of enzymes froni
intestinal mucosa in an in vivo experimental model
was described. Segmental perfusion of proximal jejü-
num of the rat was applied to study the liberation of
enzymes from the mucosa cells under the influence
of Ringer solution and bile salts. Besides plasma
membrane enzymes cytosol enzymes were released
in considerable quantities. In contrast, lysosomal and
mitochondrial enzymes did not enter the perfusion
medium, a finding that excludes a serious injury to
the mucusa cells.
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Prior to these experiments an in vitro investigation
was conducted using the well-known Wilson-Wise-
man method. The results were strikingly different.
The method has long been used for the study of the
assimilation of food stüffs. Recently, however, it was
convincingly demonstrated by Ugolev (2, 3) that in
this model oxygenation is insufficient. Therefore,
our results obtained with this method should be use-
ful to demonstrate the effect of hypoxia on enzyme
release from intestinal mucosa. In this communica-
tion the results of the in vitro method are presented
in comparison with those of the in vivo model.
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Material and Methods
Exper imen ta l modeis
Female white Wistar rats of an average weight of 200 g were used.
They had been on a Standard diet but were fasted overnight prior
to the experiment. The method of segmental perfusion in vivo has
been described previously (1). The Wilson-Wiseman method (4)
was applied äs described by Suda & Ueda (5). 30 cm of the prox-
imal jejunum were removed and carefully everted. One end was
ligated, the interior filled with 2-3 ml of Ringer solution and the
other end attached to a narrow glass tube which was then lowered
into a large tube filled with 55 ml of bath fluid at 37 °C. Carbogen
gas (oxygen: carbon dioxide 95:5) was slowly circulated through
two additional openings of the large tube. The bath fluid consisted
of Ringer solution for warm-blooded animals (9.50 g NaCl, 0.10 g
KC1, 0.20 g CaCl2, 0.15 g NaHCO3, and 1.00 g glucose per liter)
without and with 10 mmol/1 sodium taurocholate. This bile salt at
this concentration was clearly effective in the in vivo experiments
in releasing brush border and cytosol enzymes. At intervals during
incubation 2 ml samples of the bath fluid were removed, and re-
placed by Ringer solution. The dilution was corrected by calcula-
tion.
Enzyme and protein determinations
Five plasma membrane, five cytosol and two lysosomal enzymes
(see tab. 1) and protein were determined äs described in the pre^
vious paper (1). Inhibition of enzymes by 10 mmol/1 taurocholate
was corrected by caicülation; activation was not corrected because
it is negligible (alkaline phosphatase, a-l,4^glucosidase) or incal-
culable (enteropeptidase) (1). For comparison, the released quan-
tities of protein and enzymes were related to 20 cm of jejunal seg-
ment.
Results
The cumulative amounts of protein and enzymes re-
leased after different time intervals are given in täble
1. For better comparison, söme typical observations
are represented in figure 1. In the in vitro investiga-
tions there are sigiiificant quantities of protein and
enzymes in the medium at the beginning of the
experiments. They are due to the unavoidable aiioxic
and mechanical injury of the intestinal mucosa dur-
ing the preparation of the everted sacs. These zero
time valües might be subtracted from the values ob-
tained after incübation. In öür opinion it is more use-
fül to consider the slopes of the curves which give an
impression of the rates of enzyme release under the
different experimental conditions. In vivo, aftef an
initial lag phase a nearly linear increase can be seen.
In vitro, however, the release rätes tend to decrease
during the experiment.
The plasma membrane enzymes, with the exception
of alkaline phosphatase and alanine aminopeptidase,
tend to smaller release rates in vitro than in vivo.
This is true especially of enteropeptidase, büt the
phenomenon is also seen, though to a lesser degree,
Tab. l. Cumulative quantities of protein and enzymes released after 0, 30, 60 and 120 min of perfusion (in vivo) or incubation (in vitro).
The intermediate values estimated in the in vivo experiments were omitted (see fig. 1). Control, Ringer soiutipn; TC, the same
with 10 mmol/1 taurocholate. The number of experiments is given in parentheses. The fesults are given äs mean ± SEM.
Incubation or perfusion (min)
0 30 60 120
Protein
in vivo Control (23)
TC(20)
in vitro Control (14)
TC(13)
:
5.89 ± 0.47
6.13 ± 0.39
Alanine aminopeptidase (EC 3.4.1 1.2)
in vivo Control (24)
TC(25)
in vitro Control (13)
TC(12)
Alkaline phosphatase (EC 3.1.3
in vivo Control (22)
TC(23)
in vitro Control (12)
TC(9)
-Glutamyl transferase (EC 2.3.
in vivo Control (22)
TC(23)
in vitro Control (10)
TC(7)
Enteropeptidase (EC 3.4.21.9)
in vivo Control (22)
TC(24)*
in vitrc Control (9)
TC(9)*
-
0.065 ± 0.007
0.067 ± 0.007
-D
0.145 ± 0.011
0.142 ± 0.015
2.2)
:
0.092 ± 0.008
0.073 ± 0.005
0
0
mg -20 cm"1
5.74 ± 0.36
8.32 ± 0.34
10.76 ± 0.55
26.57 ± 1.37
U · 20 cm'1
0.042 ± 0.002
0.053 ± 0.003
0.131 ± 0.013
0.542 ± 0.033
U - 20 cm'1
0.086+ 0.005
0.127+ 0.006
0.300 ± 0.020
1.422± 0.082
U · 20 cm'1
0.084+ 0.004
0.153 ± 0.007
0.185 ± 0.015
0.659 ± 0.042
U · 20 cm-1
6.4 + 0.1
20.4 ± 1.5
1.5 ± 1.0°
89.3 ±11.3
7.83 ± 0.44 ...
12.56 ± 0.38
14.93 ± 0.60
34.06 + 1.51
0.076 ± 0.003
0.307+ 0.010
0.181 ± 0.017
0.849+ 0.047
0.134± 0.005
0.530 ± 0.014
0.479 ± 0.032
2.100+ 0.162
0.165 ± 0.005
0.719+ 0.024
0.249 ± 0.017
0.925 ± 0.049
31.9 ± 3.1
141.6 ± 7.2*
3.3 ± 1.0
107.2 ± 10.8
11.14 ± 0.61
17.95 ± 0.57
18.53 ± 0.78
41.42 ± 1.64
0.155+ 0.005
0.677+ 0.020
0.242 ± 0.021
1.120± 0.075
0.241 ± 0.006
1.439± 0.032
0.667 ± 0.045
2.911 ± 0.194
0.367+ 0.010
L827+ 0.046
0.313 ± 0.015
1.191 ± 0.059
67.2 ± 3.2
405.1 ±14.3*·
5.0 ± 1.1
* 129.8 +14.0
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Tab. 1. Continued
Incubation or perfusion (min)
0 30
-M-Glucosidase (EC 3.2.1.20)
in vivo Control (18)
TC(20)
in vitro Control (10)
TC(8)
—
0.08 ± 0.04
0.06 ± 0.03
Glycyl-glycine dipeptidase (EC 3.4.13.1, now 3.4.13
in vivo Control (24)
TC(19)
in vitro Control (8)
TC(7)
Prolidase(EC 3.4. 13.9)
in vivo Control (12)
TC(12)
in vitro Control (8)
TC(7)
Leucine aminopeptidasei(EC 3.4.
in vivo Control (20
TC(26)
in vitro Control (41)
TC(10)
—
0.60 ± 0.08
0.56 ± 0.11
-
1.02 ± 0.16
0.99 ± 0.15
11.1)
—
0.064 ± 0.003
0.067 ± 0.006
Glycyl-L-leucine dipeptidase (EC 3.4.13.2, now 3.4.
in vivo Control (16)
TC(17)
in vitro Control (7)
TC(8)
Prolinase(EC 3.4. 13.8)
in vivo Control (15)
TC(13)
in vitro Control (7)
TC(7)
ß-Glucuronidase (EC 3.2.1.31)
in vivo Control (10)
TC(10)
in vitro Control (10)
TC(9)
Arylsuljphätase A (EC 3.1.6.1)
in vivo Control (10)
tc(io)
in vitro Control (10)
TC(9)
0.44 ± 0.09
0.42 ± 0.09
0.409 ± 0.088
0.41 5 ± 0.043
-
0.60 ± 0.30
0.73 ± 0.33
8.7 ± 3.0
9.6 ± 3,2
U · 20 cm"1
0.46 ± 0.03
0.78 ± 0.05
0.78 ± 0 . 1 0
2.29 ± 0.23
.11) U · 20 cm-1
0.22 ± 0.01
0.39 ± 0.02
1.19 ± 0.09
2.73 ± 0.30
U · 20 cm"1
0.06 ± 0.01
0.23 ± 0.03
1.76 ± 0.16
4.37 ± 0.32
U · 20 cm"1
0.025 ± 0.002
0.081 ± 0.003
0.187 ± 0.016
0.521 + 0,060
13.11) u · 20 cm"1
0.25 ± 0.02
0.36 ± 0.03
6.90 ± 0.43
2.84 . ± 0.38
U · 20 cm-'
0.045 ± 0.009
0.053 ± 0.009
1.809 ± 0.173
0,916 ± 0.100
mU - 20 cm'1
0.42 ± 0.20
0
13.27 ± 1.47
60.33 ± 3.20
mU · 20 cm-1
0
0
40.7 ± 3.7
102.9 ± 10.0
60
1.26 ± 0.05
2.90 ± 0.10
1.28 ± 0.12
3.35 ± 0.36
0.44 ± 0.02
1.37 ± 0.05
1.79 ± 0.17
3.80 ± 0.37
0.11 ± 0.01
1.30 ± 0.06
2.48 ± 0.16
5.83 ± 0.46
0.044 ± 0.002
0.519 ± 0.017
0.293 ± 0.026
0.851 ± 0.107
0.60 ± 0.03
1.45 ± 0.07
11.29 ± 0.75
4.38 ± 0.32
0.099 ± 0.013
0.167+ 0.012
2.549 ± 0.220
1.181 ± 0.107
0.87 ± 0.48
0
25.5 ± 2.13
216.26 ±17.20
0
0
64.7 ± 5.6
177.8 ± 17.7
120
3.02 ± 0.06
7.09 ± 0.18
1.84 ± 0.19
4.40 + 0.47
1.19 ± 0.05
3.87 ± 0.16
2.38 ± 0.18
4.73 ± 0.42
0.36 ± 0.03
4.06 ± 0.15
3.62 ± 0.28
7.36 ± 0.63
0.103 ± 0.004
1.311+ 0.029
0.397+ 0.035
1.051 + 0.134
1.78 + 0.10
4.55 + 0.16
15.05 + 0.71
5.92 + 0.37
0.260+ 0.023
0.496+ 0.024
3.358+ 0.240
1.786+ 0.175
2.12 + 0.88
0.64 + 0.34
39.73 + 2.13
311.86 ±23.07
0
0
94.7 + 8.1
252.6 + 22.5
* not corrected (see Material and Methods section).
in the ease of a-l,4-glucosidase and -glutamyl
transferase.
By contrast, the cytosöl enzymes are released con-
siderably faster in vitro than in vivo. This is valid for
glycylgliycine dipeptidase, leucine aminopeptidase
and prolidase. As for glycyl-L-leucine dipeptidase
and prolinase, the release rates in vitro are inuch
greater in the presence of Ringer solution alone than
with Ringer and taurocholate in the medium.
The greatest differences are found for the lysosomal
enzymes which were praetically absent in the medi-
um in vivo, but could be demonstrated in considera-
ble quantities in vitro, especially under the addition-
al effect of bile sah.
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Fig. 1. Some typical examples illustrating the differences in release among enzymes of different location and stability.
O in vivo, Ringer solution
Δ A
 in vivo, Ringer solution + 10 mmol/1 taurocholate
O——O in vitro, Ringer solution
A A in vitrOi Ringer solution + 10 mmol/1 taurocholate /·/
For further explanation see Discussion.
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Discussion
Recently, it was demonstrated by Ugolev et al. (2, 3)
that füll transport capacity in the Wilson-Wiseman
method is only achieved if additional serosal oxyge-
nation is provided. In this case, for instance, the ac-
tive assiinilation of glucose is increased by 50%.
Therefore, the original in vitro method inust be con-
sidered a hypoxia model, and hypoxia must be the
main cause of the differences found between our in
vivo and in vitro experiments.
It has long been accepted in clinical enzymology that
deficient oxygen supply favours the release of cytos-
öl enzymes from the cells (6). But it is interesting to
note that in vitro glycyl-leucine dipeptidase (fig. le)
and prolinase are liberated to a considerably greater
extent in the absence than in the presence of bile
salt. This is inversely correlated with the behaviour
of the lysosomal enzymes. It might be supposed,
therefore, that some cytosol enzymes are partially
destroyed or inactivated by the action of lysosomal
cathepsins (7) which, like ß-glucuronidase (fig. If),
are likely to be released to a much greater extent in
the presence of bile salt.
Thus, enzymes such äs glycyl-leucine dipeptidase
and prolinase should have two characteristic proper-
ties, (1) they are susceptible to proteolytic attack and
(2) they can easily leave the cell across the lipid bi-
layer of the plasma membrane. Both properties may
be explained by a marked surface hydrophobicity of
the enzyme molecules (see also Lc. (8)).
In contrast to the cytosol enzymes, the removal of
the plasma membrane enzymes appears to require
energy. The type of anchoring of these enzymes in
the membrane seems to be relevant. Eriteropepti-
dase and a-l,4^glucosidase, which are readily re-
leased, are embedded superficially in the membrane
whereas alkaline phosphatase etc. are tightly an-
chored through a large transmembrane domain (9,
10,11). One might speculate that the usual shedding
of plasma membrane enzymes is caused by "peristal-
tic" movements of the microvilli which are actively
induced by way of the cytoskeleton. Another differ-
ence is constituted by the flow of the medium in the
in vivo experiments. Its absence might be another
cause of the rapidly declining release rates of entero-
peptidase and <x-l,4-glucosidase in vitro.
The lysosomal membranes are damaged by intracel-
lular acidosis (12). The appearance of lysosomal en-
zymes in the medium is clear evidence of serious cell
damage (absent in the in vivo experiments). In gen-
eral, the effects of hypoxia are enhanced by the pres-
ence of bile salt in the medium. It would be interest-
ing to know if it aggravates the effects of hypoxia by
penetrating the celis. Mitochondrial enzymes were
not estimated in the present investigation.
The general tendency towards decrease of rates of
enzyme release in the in vitro epxeriments may be
explaineä by declining synthesis due to hypoxia. The
problem of de novo synthesis of enzymes during in-
creased release by bile acid is under investigation in
our laboratory.
From a practical point of view enzymes are sensitive
indices of cellular hypoxia. This is valid for
(1) lysosomal enzymes which under hypoxic condi-
tions appear in the medium,
(2) cytosol enzymes some of which may be increased
about tenfold in relation to fully oxygenated controls
(prolidase, glycyl-L-leucine dipeptidase) in contrast
to
(3) brüsh border enzymes, especially if located su-
perficially in the plasma membrane (enteropepti-
dase, a-l,4-glucosidase), whose shedding by the
energy-deficient cells is impaired by hypoxia.
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